Most Recent

image: Setbacks and Great Leaps

Setbacks and Great Leaps

By Sue Armstrong | April 1, 2015

The tale of p53, a widely studied tumor suppressor gene, illustrates the inventiveness of researchers who turn mishaps into discoveries.

1 Comment

image: The Challenges of Precision

The Challenges of Precision

By Adam Marcus | April 1, 2015

Researchers face roadblocks to treating an individual patient’s cancer as a unique disease.

1 Comment

image: To Each His Own

To Each His Own

By Mary Beth Aberlin | April 1, 2015

Cancer treatment becomes more and more personal.


image: Two-Faced RNAs

Two-Faced RNAs

By Kerry Grens | April 1, 2015

The same microRNAs can have opposing roles in cancer.


image: From Many, One

From Many, One

By Elena E. Giorgi | April 1, 2015

Diverse mammals, including humans, have been found to carry distinct genomes in their cells. What does such genetic chimerism mean for health and disease?


image: Resisting Cancer

Resisting Cancer

By George Klein | April 1, 2015

If one out of three people develops cancer, that means two others don’t. Understanding why could lead to insights relevant to prevention and treatment.


image: Hiding in Plain Sight

Hiding in Plain Sight

By Kim Smuga-Otto | March 31, 2015

Researchers using metagenomics and single-cell sequencing identify a potential new bacterial phylum.

1 Comment

image: Genome Nation

Genome Nation

By Kerry Grens | March 27, 2015

Researchers perform whole-genome sequencing on roughly 1 percent of the Icelandic population.


image: “Yeti” Just a Himalayan Bear?

“Yeti” Just a Himalayan Bear?

By Jenny Rood | March 17, 2015

Latest analysis suggests the yeti is a known bear species, not the new, hybrid species suggested by a previous study.


image: 23andMe Enters Drug Development

23andMe Enters Drug Development

By Kerry Grens | March 12, 2015

The personal genomics firm announces plans to make medicines.


Popular Now

  1. Elena Rybak-Akimova, Chemical Kinetics Expert, Dies
  2. University of Oregon Erecting a $1-Billion Science Center
  3. Investigation Finds Signs of Misconduct in Swedish Researcher’s Papers
  4. Opinion: No, FDA Didn’t Really Approve 23andMe’s <em>BRCA</em> Test